| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 903 |
| 1 | METHOTREXATE | 735 |
| 2 | PREDNISONE | 631 |
| 3 | RITUXIMAB | 518 |
| 4 | TOCILIZUMAB | 434 |
| 5 | LEFLUNOMIDE | 422 |
| 6 | PEMBROLIZUMAB | 418 |
| 7 | BLEOMYCIN SULFATE | 417 |
| 8 | ADALIMUMAB | 412 |
| 9 | AMIODARONE HYDROCHLORIDE | 411 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIBACTERIAL HAND WIPES | 106 | 0.3174 |
| 1 | BORIC ACID | 105 | 0.2958 |
| 2 | BENZALKONIUM CHLORIDE 0.13% | 106 | 0.2819 |
| 3 | BENZALKONIUM CHLORIDE | 106 | 0.2415 |
| 4 | HUMAN RHO(D) IMMUNE GLOBULIN | 63 | 0.0613 |
| 5 | BLEOMYCIN SULFATE | 417 | 0.0402 |
| 6 | VINBLASTINE SULFATE | 78 | 0.0398 |
| 7 | GENTIAN VIOLET | 2 | 0.0385 |
| 8 | GOLD | 220 | 0.0379 |
| 9 | AMIODARONE HYDROCHLORIDE | 411 | 0.0362 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1092 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 832 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 771 |
| 3 | Platinum-based Drug [EPC] | 730 |
| 4 | Alkylating Drug [EPC] | 717 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 674 |
| 6 | Kinase Inhibitor [EPC] | 589 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 524 |
| 8 | Microtubule Inhibitor [EPC] | 467 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 435 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 12 | 0.0111 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 771 | 0.0078 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 42 | 0.0072 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 147 | 0.0068 |
| 4 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 10 | 0.0066 |
| 5 | Nitrofuran Antibacterial [EPC] | 115 | 0.0065 |
| 6 | CD30-directed Immunoconjugate [EPC] | 56 | 0.0054 |
| 7 | Lipopeptide Antibacterial [EPC] | 50 | 0.0053 |
| 8 | alpha-1 Adrenergic Agonist [EPC] | 22 | 0.0050 |
| 9 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 30 | 0.0047 |